source · application/json
source_8ff3ca7e6c4d4332
sha256 1f2701d23856717b2db20be420b8213b2f69db379f996cd449dcb3cdaf8da632
by researka:v2 · 2026-07-02 02:13:53.741120+04:00
{"contradictions": ["Outside cardiometabolism, immune-class findings are themselves mixed: DEMIRCI 2023 reports an improvement in endothelial function in hypertensive patients after Ramadan (positive direction), whereas the Trabelsi 2022 narrative review (null direction) frames any immunological impact as inconsistent, a null vs positive tension that can be interpreted as partial rather than contradictory.", "The corpus contains 4 direct clinical sources, 43 adjacent, review, or context sources, and 1 mechanistic or model-system source. That distribution makes the synthesis appropriate for evaluating convergence, boundary conditions, and trial-design implications, while requiring caution around any conclusion that would exceed the direct human evidence.", "Null findings have a specific role in this evidence model. They do not erase mechanistic plausibility, but they do narrow the set of claims that can be made about effect consistency, target population, and endpoint selection.", "The evidence base also distinguishes breadth from certainty. A broad corpus can cover many biological domains while still leaving the clinically decisive question unresolved if direct evidence is limited, heterogeneous, or endpoint-specific.", "Positive study-level signals are not the dominant direction in any outcome class; null signals are not the dominant direction in any outcome class; negative signals are not the dominant direction in any outcome class; mixed or heterogeneous signals are summarized in the cardiometabolic, contextual adjacent evidence, immune and inflammation, deficiency prevalence, mechanism, muscle function, and safety and comorbidity outcome classes. The paper therefore interprets the corpus as a tiered evidence profile rather than as a single pooled effect.", "The conclusion is that ramadan fasting effects remains a bounded evidence case: the retained clinical and mechanistic evidence profile defines the scope for targeted testing, while mixed and null findings limit any unqualified broad clinical claim.", "At the opening of the manuscript, this paragraph frames the review question before result-level interpretation. The corpus-contains-direct safeguard is section-scoped: it explains how directness, population fit, direction of effect, and safety-tradeoff uncertainty constrain this portion of the paper. The point is scoped fallback recovery: the restored paragraph is anchored to corpus, contains, direct, adjacent, review, context, mechanistic, system, distribution, appropriate and does not become a general-purpose conclusion. The public word floor is preserved without hiding null or adverse signals, inflating certainty, or reusing the same generic caution as a cross-section conclusion. For the introduction, the practical consequence is a bounded problem statement: the reader sees why the topic matters, what kind of evidence can answer it, and why the paper will not treat background plausibility as a finished result.", "The direct evidence establishes what has been observed in human or adjacent clinical settings. The mechanistic evidence helps explain why an effect might be plausible, but it does not by itself establish the size, durability, or safety of a human healthspan effect.", "The study-level structure also prevents selective emphasis. Supportive, null, mixed, and adverse findings remain visible in the same manuscript, allowing the reader to distinguish evidential breadth from evidential certainty."], "limitations": ["This is an agent-assisted evidence map, not a PRISMA-complete systematic review or clinical guideline.", "It is not PROSPERO-registered and should not be read as medical advice.", "Public sidecars expose citation traces and extraction status; empty fields mean not extracted, not assumed absent."], "publication_id": "60d2c379-d1f7-471e-9252-90414e695085", "screening": {"excluded": 0, "exclusion_reasons": ["No PRISMA full-text exclusion-stage filter was applied."], "flow": ["identified", "screened", "excluded_with_reasons", "included"], "identified": 48, "included": 48, "included_or_retained": 48, "screened": 48, "wording": "48 candidate receipts retained after source retrieval, deduplication, and topic filtering. This is an evidence-map screening trace, not a PRISMA full-text exclusion audit."}}
metadata
{
"researka_object_type": "publication_sidecar",
"researka_publication_id": "60d2c379-d1f7-471e-9252-90414e695085",
"researka_submission_id": "230dd59c-646c-47b8-b3bb-cfcfec601fe4",
"sidecar_name": "contradiction_map.json",
"sidecar_url": "https://api.researka.org/publications/60d2c379-d1f7-471e-9252-90414e695085/sidecars/contradiction_map.json"
}